Paediatric abacavir–lamivudine fixed-dose dispersible tablets and ritonavir-boosted lopinavir granules in neonates exposed to HIV (PETITE study): an open-label, two-stage, single-arm, phase 1/2, pharmacokinetic and safety trial

Autor: Bekker, Adrie, Salvadori, Nicolas, Rabie, Helena, du Toit, Samantha, Than-in-at, Kanchana, Groenewald, Marisa, Cressey, Ratchada, Nielsen, James, Capparelli, Edmund V, Lallemant, Marc, Cotton, Mark F, Cressey, Tim R *
Zdroj: In The Lancet HIV February 2024 11(2):e86-e95
Databáze: ScienceDirect